<DOC>
	<DOCNO>NCT00987948</DOCNO>
	<brief_summary>High level HIV infection within blood monocyte/macrophages ( type white cell bloodstream ) increase risk dementia HIV-infected individual . Maraviroc ( Selzentry ) HIV medication work block entry HIV cell include monocytes/macrophages use receptor call CCR5 . The study hypothesis addition Maraviroc HIV antiretroviral regimen HIV-infected individual high level HIV-infected monocyte/macrophages lead decrease level infect monocyte/macrophages decrease brain inflammation study magnetic resonance spectroscopy ( MRS , form MRI study ) .</brief_summary>
	<brief_title>Maraviroc Intensification Peripheral Blood Monocyte HIV DNA Levels</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Maraviroc</mesh_term>
	<criteria>HIV1 infection document ELISA confirm either Western blot , HIV1 culture , HIV1 antigen , plasma HIV1 RNA RTPCR bDNA time prior study entry . Receipt ARV medication uninterrupted &gt; 1 year lead screening period demonstrate HIV RNA &lt; 50 copies/ml period 1 year . '' Willingness male females childbearing potential utilize 2 effective contraception method ( 2 separate form , one must effective barrier method ) , nonheterosexually active exclusive vasectomize partner screen throughout duration study treatment 30 day follow last dose study drug . Age &gt; 18 year . Ability willingness provide write informed consent The following laboratory parameter document within 30 day prior study entry : Hemoglobin &gt; 8.0 Absolute neutrophil count &gt; 500 Platelet count &gt; 40,000 AST ( SGOT ) ALT ( SGPT ) &lt; 5 x ULN Creatinine &lt; 1.5 x ULN Lipase &lt; 2.0 x ULN Estimated creatinine clearance &gt; 60 mL/min . HIV DNA within peripheral blood mononuclear cell &gt; 100 copies/mL Not currently receive Maraviroc part ARV regimen Past present HIV opportunistic infection brain , learn disability , head injury prolong loss consciousness cognitive sequela , nonHIV risk factor may impact cognitive performance . Any factor precludes MRI scan include presence metal exposure metal work ( e.g. , metal grinder/worker ) claustrophobia History seizure disorder History myocardial infarction , angina , congestive heart failure , peripheral vascular disease , angioplasty cardiac surgery Current malignancy history past malignancy exclude basal cell CA Any immunomodulator , HIV vaccine , investigational therapy within 30 day study entry . Any vaccination within 30 day study entry . Requirement acute therapy AIDSdefining illness serious medical illness ( opinion site investigator ) within 14 day prior study entry . Other chronic illness include diabetes , autoimmune disease , endocrinopathies , except subject stable physiologic replacement therapy low testosterone thyroid level Known hypersensitivity Maraviroc Any condition , opinion investigator , would compromise subject 's ability participate study Current active substance alcohol dependence Pregnancy breastfeeding , intent become pregnant course study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>HIV</keyword>
	<keyword>dementia</keyword>
	<keyword>High HIV DNA within CD14+ PBMCs</keyword>
	<keyword>treatment experience</keyword>
</DOC>